bpc 157 human clinical trials musculoskeletal BPC-157: What the Science Actually Says Here's a nice graphic on

Hoang, D.O., FACP, FACE, CAPTAIN (select), Walter Reed National Military Medical Center, and Henry B

Compared to GHK-Cu (340 Da tripeptide), BPC-157 preferentially targets deep tissues and visceral healing, while GHK-Cu focuses on skin and dermal collagen production

Possibly, with respect to the underlying disease (which was markedly counteracted in BPC 157 rats), more activity of eNOS (the constitutive isoforms instantly increase along with COX2), and more activity of nNOS (NO produced by nNOS is thought to mediate synaptic plasticity and neuronal signaling) [103,104], may be intrinsic effects of BPC 157

Treats problems with the spine but also assists the doctor with the diagnosis

Yes, with precautions